Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compendial issues: WHO.

S Kopp-Kubel1

  • 1World Health Organization, Geneva, Switzerland.

Journal of Parenteral Science and Technology : a Publication of the Parenteral Drug Association
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

The World Health Organization (WHO) sets international standards for pharmaceutical products and promotes global drug safety and quality. WHO is exploring harmonizing drug registration requirements to support increasing manufacturing capabilities worldwide.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Nonproprietary Names (INN) for pharmaceutical substances.

Bulletin of the World Health Organizationยท1995
See all related articles

Area of Science:

  • Pharmaceutical Sciences
  • International Health Policy
  • Regulatory Affairs

Background:

  • The World Health Organization (WHO) is an international body representing 182 member states.
  • WHO holds a constitutional mandate to establish and promote international standards for biological, pharmaceutical, and related products.
  • Current WHO programs encompass Good Manufacturing Practices, the International Pharmacopoeia, International Nonproprietary Names (INN), and the WHO Certification Scheme.

Purpose of the Study:

  • To outline the World Health Organization's role in setting international pharmaceutical standards.
  • To highlight key WHO programs related to drug safety, efficacy, and quality.
  • To address the growing need for harmonization in drug registration and quality control.

Main Methods:

Related Experiment Videos

  • Review of WHO's constitutional mandate and established programs.
  • Analysis of current initiatives focusing on international pharmaceutical standards.
  • Examination of the feasibility of harmonizing drug registration requirements.

Main Results:

  • WHO actively develops and promotes international standards for pharmaceutical products.
  • A range of programs exist to ensure drug quality, safety, and efficacy globally.
  • There is an increasing focus on harmonizing drug registration and quality control processes.

Conclusions:

  • The WHO plays a critical role in global pharmaceutical regulation and standardization.
  • Harmonization of drug registration is essential given the rise in global manufacturing.
  • Continued international collaboration is vital for ensuring access to safe and effective medicines.